{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-26-017833","form_type":"8-K","ticker":"LIXT","cik":"0001335105","company_name":"LIXTE BIOTECHNOLOGY HOLDINGS, INC.","filed_at":"2026-04-17T23:59:59+00:00","discovered_at":"2026-05-14T18:02:32.168206+00:00","generated_at":"2026-05-15T05:28:03.602724+00:00","sec_items":["5.02","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Lixte Biotechnology cancels 500,000 options, awards equal RSUs vesting immediately to CEO, CFO, and directors","bullets":["CEO Geordan Pursglove: 350,000 options cancelled, 350,000 RSUs awarded; CFO Peter Stazzone: 50,000 each.","Directors Holloway, Primus, Felix, Sawyer: each 25,000 options cancelled and RSUs awarded.","RSUs granted under 2020 Stock Incentive Plan and vested immediately on April 15, 2026.","Committee states swap provides better retention/incentive for officers and directors."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-26-017833","json":"https://secwatch.observer/filing/0001493152-26-017833.json","markdown":"https://secwatch.observer/filing/0001493152-26-017833.md","text":"https://secwatch.observer/filing/0001493152-26-017833.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1335105/000149315226017833/0001493152-26-017833-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1335105/000149315226017833/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T05:28:03.602724+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}